BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 8552573)

  • 1. Multiparameter digital image analysis of biliary, ampullary, and pancreatic adenocarcinomas.
    Yeaton P; Kiss R; DePrez C; Salmon I; Pasteels JL; Jones RS; Frierson HF
    Mod Pathol; 1995 Oct; 8(8):843-7. PubMed ID: 8552573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of image cytometry to classify biliary and ampullary adenocarcinomas.
    Yeaton P; Frierson HF; Hittelet A; Duckworth C; DePrez C; Bourgeois N; Salmon I; Jones RS; Kiss R; Decaestecker C
    Anal Quant Cytol Histol; 1998 Dec; 20(6):509-16. PubMed ID: 9870103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical staining in the diagnosis of pancreatobiliary and ampulla of Vater adenocarcinoma: application of CDX2, CK17, MUC1, and MUC2.
    Chu PG; Schwarz RE; Lau SK; Yen Y; Weiss LM
    Am J Surg Pathol; 2005 Mar; 29(3):359-67. PubMed ID: 15725805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Periampullary carcinoma or tumor of the ampulla of Vater?].
    Vasilescu C; Herlea V; Stoicescu M
    Chirurgia (Bucur); 2000; 95(5):401-6. PubMed ID: 14870549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neoplasms of the ampulla of vater with concurrent pancreatic intraductal neoplasia: a histological and molecular study.
    Agoff SN; Crispin DA; Bronner MP; Dail DH; Hawes SE; Haggitt RC
    Mod Pathol; 2001 Mar; 14(3):139-46. PubMed ID: 11266517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intestinal-type and pancreatobiliary-type adenocarcinomas: how does ampullary carcinoma differ from other periampullary malignancies?
    Westgaard A; Pomianowska E; Clausen OP; Gladhaug IP
    Ann Surg Oncol; 2013 Feb; 20(2):430-9. PubMed ID: 22956064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrapancreatic distal common bile duct carcinoma: Analysis, staging considerations, and comparison with pancreatic ductal and ampullary adenocarcinomas.
    Gonzalez RS; Bagci P; Basturk O; Reid MD; Balci S; Knight JH; Kong SY; Memis B; Jang KT; Ohike N; Tajiri T; Bandyopadhyay S; Krasinskas AM; Kim GE; Cheng JD; Adsay NV
    Mod Pathol; 2016 Nov; 29(11):1358-1369. PubMed ID: 27469329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of the caudal-type homeodomain transcription factors CDX 1/2 and outcome in carcinomas of the ampulla of Vater.
    Hansel DE; Maitra A; Lin JW; Goggins M; Argani P; Yeo CJ; Piantadosi S; Leach SD; Biankin AV
    J Clin Oncol; 2005 Mar; 23(9):1811-8. PubMed ID: 15774774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histopathologic Analysis of Pancreaticoduodenectomy Specimen.
    Dhakhwa R; Kafle N
    JNMA J Nepal Med Assoc; 2016; 55(204):79-85. PubMed ID: 28029673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumors of the ampulla of vater: histopathologic classification and predictors of survival.
    Carter JT; Grenert JP; Rubenstein L; Stewart L; Way LW
    J Am Coll Surg; 2008 Aug; 207(2):210-8. PubMed ID: 18656049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does lymph node ratio impact survival in resected periampullary malignancies?
    Hurtuk MG; Hughes C; Shoup M; Aranha GV
    Am J Surg; 2009 Mar; 197(3):348-52. PubMed ID: 19245913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokeratins 7, 17, and 20 reactivity in pancreatic and ampulla of vater adenocarcinomas. Percentage of positivity and distribution is affected by the cut-point threshold.
    Goldstein NS; Bassi D
    Am J Clin Pathol; 2001 May; 115(5):695-702. PubMed ID: 11345833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Podocalyxin-like protein 1 expression is useful to differentiate pancreatic ductal adenocarcinomas from adenocarcinomas of the biliary and gastrointestinal tracts.
    Ney JT; Zhou H; Sipos B; Büttner R; Chen X; Klöppel G; Gütgemann I
    Hum Pathol; 2007 Feb; 38(2):359-64. PubMed ID: 17137615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Morphometric microvascular characteristics in the prognosis of pancreatic and ampullary carcinoma.
    Giannopoulos G; Kavantzas N; Parasi A; Tiniakos D; Peros G; Tzanakis N; Patsouris E; Pavlakis K
    Pancreas; 2007 Jul; 35(1):47-52. PubMed ID: 17575545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrence and prognostic factors of ampullary carcinoma after radical resection: comparison with distal extrahepatic cholangiocarcinoma.
    Woo SM; Ryu JK; Lee SH; Yoo JW; Park JK; Kim YT; Jang JY; Kim SW; Kang GH; Yoon YB
    Ann Surg Oncol; 2007 Nov; 14(11):3195-201. PubMed ID: 17710498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-pancreatic periampullary adenocarcinomas: an explanation for favorable prognosis.
    Katz MH; Bouvet M; Al-Refaie W; Gilpin EA; Moossa AR
    Hepatogastroenterology; 2004; 51(57):842-6. PubMed ID: 15143931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implications of histological grade of tumour for the prognosis of radically resected periampullary adenocarcinoma.
    Sellner FJ; Riegler FM; Machacek E
    Eur J Surg; 1999 Sep; 165(9):865-70. PubMed ID: 10533763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multi-detector spiral CT diagnosis of common bile duct ampullary carcinoma.
    Zhao DZ; Guo Y; Sun YP; Liu HM; Zhang Z; Ma QL; Wang YS; Chen CL
    Eur Rev Med Pharmacol Sci; 2017 Aug; 21(16):3549-3553. PubMed ID: 28925490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Results of surgical treatment in ampullary and pancreatic carcinoma and its prognostic parameters after R0-resection].
    Ridwelski K; Meyer F; Schmidt U; Lippert H
    Zentralbl Chir; 2005 Aug; 130(4):353-61. PubMed ID: 16103961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumour origin, diagnostic accuracy and histopathological evaluation in patients with periampullary cancer: nationwide cohort study.
    Byrling J; Ghazi S; Andersson B
    BJS Open; 2023 Sep; 7(5):. PubMed ID: 37864577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.